Lipid Metabolism And Ketone Bodies - USMLE Step 1

1. The metabolic state in his liver that promotes this high rate of ketogenesis is primarily characterized by which of the following?
   Answer: A high NADH/NAD+ ratio In alcoholic ketoacidosis, the metabolism of ethanol by alcohol dehydrogenase and aldehyde dehydrogenase generates a large amount of NADH, leading to a very high NADH/NAD+ ratio. This high ratio shunts oxaloacetate towards malate and pyruvate towards lactate, depleting the substrates for gluconeogenesis (causing hypoglycemia) and the TCA cycle. The lack of oxaloacetate prevents acetyl-CoA from entering the TCA cycle, diverting it instead towards the synthesis of ketone bodies.
2. The medication he was prescribed most likely inhibits the rate-limiting step in the synthesis of which of the following molecules?
   Answer: Cholesterol The patient was most likely prescribed a statin (e.g., atorvastatin, simvastatin), which is a first-line agent for lowering LDL cholesterol. Statins are competitive inhibitors of HMG-CoA reductase, the rate-limiting enzyme in the de novo synthesis of cholesterol. By reducing hepatic cholesterol synthesis, statins cause an upregulation of LDL receptors on the surface of hepatocytes, leading to increased clearance of LDL from the circulation.
3. Which of the following molecules is the product of this spontaneous reaction and is often detectable on the breath of individuals in ketosis?
   Answer: Acetone Acetoacetate is an unstable beta-keto acid that can spontaneously (non-enzymatically) decarboxylate to form acetone. Acetone is a volatile compound that is not metabolized for energy and is excreted via the lungs and kidneys. Its exhalation gives the characteristic 'fruity' or 'nail polish remover' odor to the breath of individuals in severe ketosis, such as in diabetic ketoacidosis.
4. Which of the following molecules is the most potent allosteric activator of the rate-limiting enzyme in this process?
   Answer: Citrate The rate-limiting enzyme in fatty acid synthesis is acetyl-CoA carboxylase (ACC). In the well-fed state, high levels of glucose lead to increased glycolysis and TCA cycle activity. Excess citrate from the TCA cycle is shuttled out of the mitochondria into the cytoplasm, where it acts as a potent allosteric activator of ACC, promoting the conversion of acetyl-CoA to malonyl-CoA and committing the carbons to fatty acid synthesis.
5. Which of the following metabolic pathways is the primary source of the NADPH required for this process?
   Answer: Pentose phosphate pathway The reductive synthesis of fatty acids requires a significant amount of NADPH. The primary source of this NADPH in the cytoplasm is the pentose phosphate pathway (PPP), specifically the oxidative branch reactions catalyzed by glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. Malic enzyme also contributes to NADPH production.
6. This disorder is most likely associated with a defect in which of the following apolipoproteins?
   Answer: Apolipoprotein E The patient's presentation with palmar striae and elevated cholesterol and triglycerides is characteristic of Type III hyperlipoproteinemia (dysbetalipoproteinemia). This condition is most commonly caused by homozygosity for the ApoE2 isoform of apolipoprotein E. ApoE is necessary for the hepatic uptake of chylomicron remnants and VLDL remnants (IDL). A defect in ApoE leads to the accumulation of these remnant particles in the circulation.
7. The transport of which of the following molecules into the mitochondria is most likely impaired in this patient?
   Answer: Long-chain fatty acids This patient's symptoms of cardiomyopathy, skeletal myopathy, and hypoketotic hypoglycemia are characteristic of a primary carnitine deficiency or a defect in the carnitine shuttle system (e.g., CPT I or CPT II deficiency). This system is responsible for transporting long-chain fatty acids from the cytoplasm into the mitochondrial matrix for beta-oxidation. The impaired transport leads to lipid accumulation in tissues like muscle and heart that rely on fatty acids for energy.
8. This patient's condition is most likely caused by a deficiency in an enzyme involved in which of the following metabolic processes?
   Answer: Beta-oxidation of fatty acids The patient's presentation of hypoketotic hypoglycemia during a period of fasting (due to illness) is classic for a defect in fatty acid oxidation. The accumulation of medium-chain acylcarnitines points specifically to medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. In this condition, fatty acids cannot be broken down to produce acetyl-CoA for ketone body synthesis or ATP production, leading to a dangerous reliance on glucose and subsequent hypoglycemia when glycogen stores are depleted.
9. This condition is most likely caused by a deficiency of which enzyme?
   Answer: Lipoprotein lipase This presentation is classic for Type I hyperlipoproteinemia (familial chylomicronemia syndrome), an autosomal recessive disorder caused by a deficiency in either lipoprotein lipase (LPL) or its cofactor, apolipoprotein C-II. LPL is responsible for hydrolyzing triglycerides within chylomicrons and VLDL in the capillary beds. Its deficiency leads to the massive accumulation of chylomicrons in the plasma, causing extremely high triglyceride levels, pancreatitis, and eruptive xanthomas.
10. This patient's condition is caused by a defect in a protein essential for which of the following processes?
    Answer: Assembly and secretion of chylomicrons and VLDL This is a classic presentation of abetalipoproteinemia, an autosomal recessive disorder caused by mutations in the gene for microsomal triglyceride transfer protein (MTP). MTP is crucial for loading lipids onto apolipoprotein B, a necessary step for the assembly and secretion of chylomicrons from enterocytes and VLDL from hepatocytes. The lack of these lipoproteins leads to severe fat malabsorption, steatorrhea, and deficiencies in fat-soluble vitamins, which causes the characteristic acanthocytosis (thorny RBCs).
11. This compensatory mechanism leads to an upregulation of the activity of which of the following enzymes?
    Answer: HMG-CoA reductase Bile acid sequestrants like cholestyramine interrupt the enterohepatic circulation of bile acids. The resulting depletion of the hepatic bile acid pool relieves feedback inhibition on 7-alpha-hydroxylase, increasing bile acid synthesis from cholesterol. This depletes hepatic cholesterol stores, which triggers compensatory upregulation of HMG-CoA reductase (the rate-limiting enzyme in cholesterol synthesis) and increased LDL receptor expression. This compensatory increase in cholesterol synthesis is the primary mechanism by which these drugs ultimately lower plasma LDL cholesterol.
12. After this prolonged period of starvation, which of the following serves as the primary fuel source for his brain?
    Answer: Beta-hydroxybutyrate During prolonged starvation (after several days), the liver produces large quantities of ketone bodies (acetoacetate and beta-hydroxybutyrate) from fatty acid oxidation. The brain, which cannot use fatty acids for fuel, adapts to use ketone bodies as its primary energy source. This adaptation is crucial for 'sparing' protein, as it reduces the need for gluconeogenesis from amino acids and thus preserves muscle mass.
13. This toxin causes its effects by directly inhibiting which of the following enzymes?
    Answer: Acyl-CoA dehydrogenase Hypoglycin A, the toxin in unripe ackee fruit, is metabolized to methylenecyclopropylacetyl-CoA (MCPA-CoA). This metabolite irreversibly inhibits several acyl-CoA dehydrogenases, key enzymes in the beta-oxidation of fatty acids. The inhibition of beta-oxidation prevents the production of acetyl-CoA, NADH, and FADH2 from fats, leading to hypoketotic hypoglycemia as the body cannot generate alternative fuels or support gluconeogenesis during fasting.
14. The final TCA cycle intermediate produced from propionyl-CoA metabolism is which of the following?
    Answer: Succinyl-CoA The three-carbon propionyl-CoA is carboxylated to D-methylmalonyl-CoA, which is then isomerized to L-methylmalonyl-CoA. Finally, methylmalonyl-CoA mutase (a vitamin B12-dependent enzyme) converts L-methylmalonyl-CoA to succinyl-CoA. Succinyl-CoA is an intermediate of the citric acid cycle and can be converted to oxaloacetate for entry into gluconeogenesis, making odd-chain fatty acids a minor glucogenic source.
15. The primary regulatory step that ensures active beta-oxidation in this state involves the inhibition of which of the following enzymes?
    Answer: Acetyl-CoA carboxylase During fasting, high glucagon levels lead to the phosphorylation and inactivation of acetyl-CoA carboxylase (ACC). This reduces the production of malonyl-CoA. Malonyl-CoA is a potent inhibitor of carnitine palmitoyltransferase I (CPT-I), the enzyme that transports fatty acids into the mitochondria. By inhibiting ACC, malonyl-CoA levels fall, which relieves the inhibition on CPT-I and allows for the robust transport and oxidation of fatty acids.
16. The production of ketones in her liver is primarily driven by an increased flux of which of the following substrates into the mitochondria?
    Answer: Acetyl-CoA derived from fatty acids In diabetic ketoacidosis (DKA), profound insulin deficiency leads to uncontrolled lipolysis, releasing large amounts of fatty acids from adipose tissue. These fatty acids are transported to the liver and undergo beta-oxidation, generating a massive amount of acetyl-CoA. The capacity of the TCA cycle is overwhelmed, and the excess acetyl-CoA is shunted into the ketogenesis pathway to produce acetoacetate and beta-hydroxybutyrate.
17. This is because hepatocytes lack which of the following enzymes?
    Answer: Succinyl-CoA-acetoacetate-CoA transferase (Thiophorase) The liver is the site of ketogenesis but cannot perform ketolysis (breakdown of ketone bodies). The key enzyme required for the utilization of acetoacetate is succinyl-CoA-acetoacetate-CoA transferase (also known as thiophorase), which converts acetoacetate to acetoacetyl-CoA. Hepatocytes lack this enzyme, ensuring that the ketone bodies they produce are exported for use by peripheral tissues rather than being consumed locally.
18. This patient's condition is most likely caused by a genetic defect affecting which of the following?
    Answer: LDL receptors The clinical presentation of tendon xanthomas, premature cardiovascular disease, and markedly elevated LDL cholesterol is classic for familial hypercholesterolemia (FH). This is an autosomal dominant disorder most commonly caused by mutations in the LDL receptor gene. Defective LDL receptors impair the clearance of LDL particles from the circulation, leading to their accumulation and deposition in tissues like tendons and arteries.
19. Which of the following enzymes, activated by apolipoprotein A-I, is responsible for this reaction?
    Answer: Lecithin-cholesterol acyltransferase (LCAT) Lecithin-cholesterol acyltransferase (LCAT) is an enzyme found in the plasma that is associated with HDL particles. It is activated by ApoA-I, the primary apolipoprotein on HDL. LCAT catalyzes the formation of cholesteryl esters from free cholesterol and phosphatidylcholine (lecithin). This esterification is crucial for the maturation of HDL particles and for creating a concentration gradient that promotes the efflux of more cholesterol from peripheral cells.
20. This constellation of findings is most consistent with a disorder affecting which of the following cellular organelles?
    Answer: Peroxisomes The patient's presentation is characteristic of Zellweger syndrome, a peroxisomal biogenesis disorder. Peroxisomes are responsible for the initial beta-oxidation of very-long-chain fatty acids (VLCFAs). In disorders like Zellweger syndrome, defective peroxisomes lead to the accumulation of VLCFAs in tissues and plasma, causing severe neurologic deficits and organ dysfunction.

Start this quiz